Viking Therapeutics VKTX outperformed the market in the last 5 years by 7.69% annually, producing an average annual return 15.12%. Viking Therapeutics currently has a market cap of $641.88 millions. VKTX Stock: $100 Purchased 5 Years Ago. Based on VKTX's current price of $8.37, an investor would have $202.17 today. What's the point? This article reveals the key insight that you should take away from it. It shows how compounded returns can impact your cash growth over a long period of time.
Benzinga does not provide investment advice. All rights reserved.Posted In: BZI-PODEarningsNewsDividends